Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit ...

Business Medtronic to spin off diabetes business, form new company The separation is expected to be completed in 18 months.

Medtronic will spin off its $2.8B diabetes unit into a new public company, focusing on high-margin growth markets in medical technology.

Medtronic bumped up its dividend payout and unveiled plans to spin off its diabetes business as the medical-device company targeted revenue growth for the new fiscal year of roughly 5%.

Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.

News National business Medtronic ventilators helped save lives during the pandemic, so why is the company shutting down the business? March 17, 2025 Updated Mon., March 17, 2025 at 12:04 p.m.

Key players in the Europe implantable loop recorders market are actively advancing the field through various initiatives and collaborations. For instance, in April 2022, Medtronic announced the ...

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Europe Implantable Loop Recorders Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. Key players in ...